These Human IFN-Beta ELISAs are highly sensitive immunoassays (< 3 pg/ml LLOQ) developed to measure human interferon beta (IFN-Beta) in specific matrices (e.g. healthy and disease sera, plasma, tissue culture media (TCM)). These high sensitivity assays display no inhibition of human IFN-Beta detection in the presence of 3-Log excess of soluble IFN-Alpha/Beta Receptor 2 (sIFNAR2) protein, thus measuring "total" IFN-Beta.
If you would like assistance selecting the kit that would work best for your research needs, contact PBL by chat, phone (+1 732-777-9123) or e-mail.
|High Sensitivity Quantification||2.34 pg/ml||1.2 pg/ml|
|Robust Sample Matrix Compatibility||Tissue Culture Media (TCM)||TCM, Plasma, Healthy, and Autoimmune Disease Sera|
|Interference by sIFNAR2||No||No|
- Validation of a Highly Sensitive Immunoassay for the Quantitation of Interferon Beta in Autoimmune Sera
- Performance Characterization of a High Sensitivity Human Interferon Beta ELISA Kit In Healthy Serum, Patient Serum and Plasma Samples
- Optimization and Validation of an ELISA kit for the Quantification of Four Interferon Beta (IFN-β) Marketed Compounds in Human Serum